Human Immunology

Papers
(The TQCC of Human Immunology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
The changing landscape of HLA typing: Understanding how and when HLA typing data can be used with confidence from bench to bedside594
O21 Estimating rates of immunologically incompatible organ offers caused by use of antigen-level deceased donor HLA typing for allocation47
O35 Detection of circulating HLA-E in cancer patients: Potential application in cancer immunotherapy45
P210 The impact of HLA-DPB1 disparity on clinical outcome post unrelated hematopoietic stem cell transplantation between 2016 and 2021 – A single center experience44
P400 Extending a virtual crossmatch analysis and reporting workflow to include HLA eplet mismatch load with risk stratification for post transplant kidney clinical decision support36
P221 Identifying the specificity of non-HLA antibodies in flow cytometry crossmatch positive, HLA DSA negative patient sera36
P401 Successful removal of flow cytometry crossmatch interference by a novel rituximab biosimilar36
P523 IgM DSA – Can they be detected before IgG DSA35
P702 Validation of Omixon NanoTYPE HLA typing using Oxford Nanopore Technologies (ONT)28
P2RX1-Negative neutrophils promote the immunosuppressive microenvironment in Non-Small cell lung cancer by Upregulating PD-L1 expression27
Genomic collision at the LIMS-1 locus increases risk of cellular mediated allograft rejection in heart transplanted recipients27
Reduction of HLA antibodies by bi-specific antibody blinatumomab25
HLA tailored immunosuppression in living related pediatric kidney transplants in a low-income country. Cost and survival benefits25
Concentration-dependent antibody specificity profiles of human leukocyte DQ antigens and predictions of functional epitopes24
Endothelial derived extracellular vesicles express high level of HLA class II molecules under inflammatory conditions24
Simplified technique sensitive washing steps for a robust hybrid capture target enrichment NGS assay23
Novel null allele discovered by rapid next-gen sequencing22
Changes in T helper cell-related factors in patients with type 2 diabetes mellitus after empagliflozin therapy20
Power BI for HLA20
Microarray analysis of autoantibodies can identify future Systemic Lupus Erythematosus patients20
Impact of Tocilizumab treatment on the reduction of angiotensin II type 1 receptor (AT1R) antibodies19
HLA-DR/DQ molecular mismatches for risk stratification and prediction of development of de novo donor-specific antibodies in cardiac allogeneic transplantation19
A buccal swab DNA extraction method for Next Generation Sequencing18
Novel HLA-A, -B, -C and -DRB1 alleles identified in the Australian New South Wales tissue typing laboratory18
Donor specific antibodies to DQ antigens are rare in DR antigen matched kidney transplants18
FOXP3+/CD68+ ratio within the tumor microenvironment may serve as a potential prognostic factor in classical Hodgkin lymphoma18
Investigation of immune checkpoint molecules (CTLA-4, PD-1, PD-L1, Tim-3) expressions in preeclampsia: A comparative study of membranous and soluble forms17
T cell senescence and impaired CMV-specific response are associated with infection risk in kidney transplant recipients17
High fructose diet: A risk factor for immune system dysregulation16
P403 The adsorption crossmatch cells and elution (AXE) technique to identify true HLA specific antibodies16
Single-cell transcriptomics of peripheral blood mononuclear cells indicates impaired immune and inflammatory responses in alcohol-associated hepatitis16
Assessing impacts of transfusions on HLA sensitization in pre-hematopoietic stem cell transplant patients16
Oral abstracts (OR)15
P608 Recipient allelic imbalance in short tandem repeats chimerism testing indicates disease relapse15
Nomenclature for factors of the HLA system, update October, November and December 202215
O27 A web-based visualization tool for asymmetric linkage disequilibrium (ALD) between amino acid positions of classical HLA loci in US populations15
Evaluation of the performance of next generation sequencing ABO probes in a solid organ transplant population14
HLA typing by Next Generation Sequencing (NGS): Validation using MGI DNBSEQ-G9914
Comparative analysis of serum pretreatment strategies to remove non-specific serum interference in HLA antibody assessment14
Uncovering the rarity: DR7-DR53-DQ9 haplotype in two Caucasian patients14
Association of killer cell immunoglobulin-like receptor genes with primary Sjögren’s syndrome among Chinese population13
Allele and eight-locus haplotype frequencies in population of Belgorod region, Russia13
Correlation of serum vitamin D levels with serum interleukin-23 levels in patients of ulcerative colitis13
Epitope mismatch load as potential driver of rejection in xenotransplantation13
Enhanced prediction of antigen and antibody binding interface using ESM-2 and Bi-LSTM13
COVID-19 infection and vaccination rarely impact HLA antibody profile in waitlisted renal transplant candidates- a multicenter cohort13
Population study to define HLA in Mohawk First Nation in Quebec13
Immune-regulatory properties carried by human amnion epithelial cells: Focus on the role of HLA-G and adenosinergic ectoenzymes13
DNA methylation and expression of LGR6 gene in ankylosing spondylitis: A case-control study13
Oral abstracts (OR)12
Next-generation sequencing and clinical histocompatibility testing11
Front Matter11
Soluble HLA-G is upregulated in serum of patients with severe COVID-1911
Correlation of serum matrix metalloproteinase 3 with osteoporosis in patients of postmenopausal rheumatoid arthritis11
O10 Common, intermediate, well-documented and rare HLA eplets in the world population: epCIWDR version 1.0.011
A snapshot of human leukocyte antigen (HLA) diversity using data from the Allele Frequency Net Database11
Different immunoregulatory components at the decidua basalis of oocyte donation pregnancies11
Guanylate binding protein1 alters expression of the poly I: C induced cytokines/chemokines and MAP kinases in macrophages11
P527 We have seen it all: Hemi-, homo-, hetero- and now tri-zygous HLA-DR – Unique case described in a healthy donor10
Single-cell analysis unveils immune dysregulation and EBV-driven lymphoproliferative disorder in pediatric liver transplant recipients10
HLA study in Mexico Nahua/Aztec Amerindians: Close relatedness to the ancient Central America ethnic groups10
P209 Adsorption/elution experiments reveal that 166DG and 166ES eplets cross-react10
Correlation of autoimmune response and immune system components in the progression of IgA nephropathy: A comparative study10
Concurrent typing of over 4000 samples by long-range PCR amplicon-based NGS and rSSO revealed the need to verify NGS typing for HLA allelic dropouts10
P517 Assessment of the effect of UNOS new CPRA calculator, implemented in January 2023, on sensitized kidney and pancreas patient population at Cedars Sinai Medical Center10
Imputing high-resolution genotypes from serological typing in a large clinical cohort10
HLA-disease association and pleiotropy landscape in over 235,000 Finns10
P104 Clinical validation of next generation sequencing-based engraftment monitoring for pediatric patients after hematopoietic cell transplantation10
HLA-DR, -DP, -DQ expression status of parathyroid tissue as a potential parathyroid donor selection criteria and review of literature9
The impact of PIRCHE-II and ischemia reperfusion injury on dynamics of CD4+ T memory cells in liver transplant recipients9
Generation of antigen-specific T lymphocytes targeting Wilms tumor 1 using activated B cells9
Isolating HLA-specific IgM and IgG from serum using different MagSort elution buffers9
De novo production of granulocyte-macrophage colony-stimulating factor antibodies following hematopoietic stem cell transplantation from HLA-matched unrelated donors is associated with acute graft-ver9
Reporting HLA antigens for the DRB3/4/5 Locus at the first field in UNet would decrease rates of deceased donor offer refusal9
Evaluating double-peak melt curves for the LinkSeqTM HLA-B*27 assay9
Impact of HLA polymorphisms on the susceptibility to SARS-CoV-2 infection and related mortality in patients with renal replacement therapy9
Identification of highly conserved surface-exposed peptides of spike protein for multiepitope vaccine design against emerging omicron variants: An immunoinformatic approach8
Class II HLA in Georgia Caucasus Tbilisi Georgians and their Mediterranean ancestry: The Usko Mediterranean languages8
Combined next generation sequencing for HLA typing and chimerism testing8
Sex-dependent regulation of interferon-γ receptor expression in pulmonary tuberculosis8
Intronic region polymorphisms of autophagy gene ATG16L1 predispose individuals to Hepatitis B virus infection8
Risk HLA alleles in South America and potential new epitopes for SARS-CoV28
Point-Counterpoint: Desensitization to improve the likelihood of lung transplantation8
Intradermal lymphocyte therapy: A promising treatment for recurrent pregnancy loss in patients without anti-TPO antibodies8
Defining a normal reference range for B cells: A key to diagnosing humoral inborn errors of immunity8
The role of the HLA allelic repertoire on the clinical severity of COVID-19 in Canadians, living in the Saskatchewan province8
Expression level of immune checkpoint inhibitory factors in preeclampsia7
P609 Performance of single antigen plus ExPlex and PRA bead assays in challenging cases of allo-hematopoietic cell transplant patients7
Mechanism of LMNB1 activating GPR84 through JAK-STAT pathway to mediate M2 macrophage polarization in lung cancer7
Resolving a relevant DPB1 Exon 3 polymorphism by HLA sequencing7
Role of T follicular helper cells in autoimmune rheumatic Diseases: A systematic review on immunopathogenesis and response to treatment7
Exploring bioinformatics tools for graft-versus-host disease risk prediction in hematopoietic cell transplantation: A study conducted at a Mexican center7
Tools for optimizing risk assessment in hematopoietic cell transplant – What can we get away with?7
P120 Successful Daratumumab desensitization strategy in a highly sensitized heart transplant patient7
P623 The A24 mystery – The missing link between solid-phase and cell-based assays7
Challenges for the standardized reporting of NGS HLA genotyping: Surveying gaps between clinical and research laboratories7
Establishing the relationship between an adopted recipient and their HLA-matched related donor7
P709 HLA Class I and II expression on T and B cells from deceased donor peripheral blood, lymph nodes and spleen: Is peripheral blood an equal specimen for physical crossmatch?7
Nomenclature for factors of the HLA system, update January, February and March 20247
Differences in T cell immune-related lncRNA and mRNA expression patterns between right- and left-sided colorectal cancers7
Evaluation of cfDNA extraction method: for monitoring donor-derived cell-free DNA post-transplantation7
Sensitive and fast NGS-based chimerism monitoring using ONT sequencing6
Role of miRNA-155 in macrophage polarisation in stage III/IV periodontitis with type II diabetes mellitus: An analytical case-control study6
Dr. James M. Mathew appointed Editor-in-Chief of Human Immunology6
Front Matter6
Diagnosing coeliac disease: A literature review6
CTLs, NK cells and NK-derived EVs against breast cancer6
Reduced levels of liver kinase B1 in small extracellular vesicles as a predictor for chronic lung allograft dysfunction in cystic fibrosis lung transplant recipients6
Feasibility of long fragment hybrid capture for long-read sequencing of HLA and beyond6
Cretan HLA genetics supports its early Minoan culture as a link between North Africa and Europe6
Use of titration for improving quantitative evaluation of Anti-HLA antibodies by SAB5
P200 Evaluation of PreSorb beads in removing nonspecific reactivities in HLA antibody test by luminex solid phase single antigen beads assay5
P301 The clinical course of a pre-existing, weak DSA targeting HLA-DR5
Uncovering new potentials: High resolution deceased donor human leukocyte antigen typing in less than 4 hours5
Nomenclature for factors of the HLA system, update October, November and December 20245
Contribution of survivin to the immune system, allergies and autoimmune diseases5
Evaluation of serum soluble HLA-G levels post-recovery from COVID-19 and post-vaccination (Sinopharm and Pfizer-BioNTech)5
P100 HLA-Cw epitope analysis can resolve positive physical flow cytometry crossmatch in absence of donor-specific antibodies and prozone effect – A case study5
P211 The Mayo Clinic Arizona virtual crossmatch algorithm supporting the largest solid organ transplant program in the United States5
Altered microRNA expression profile is linked to T-cell exhaustion-related pathways in pediatric patients with acute lymphoblastic leukemia5
Antigen presentation in SARS-CoV-2 infection: the role of class I HLA and ERAP polymorphisms5
Reducing number of laboratories performing complement dependent cytotoxicity crossmatching: Reasons and conclusions5
New challenges, new opportunities: Next generation sequencing and its place in the advancement of HLA typing5
Antigen-specific immunotherapy for platelet alloimmune disorders5
P123 HLA diversity in Brazilian population: Detection of 48 new alleles by next-generation sequencing5
P219 Kidney transplantation across pre-existing DSA using solely virtual crossmatch results5
Reconstitution of T cells at three months after stem cell transplant influences the discovery of predictive markers of relapse5
Association analysis of T and B-cell epitopes with humoral alloimmunisation in kidney transplantation: A Tunisian cohort study5
Th1 or Th2 cytokines are correlated with Tregs and T cell subsets and pregnancy outcomes in patients with autoimmune thyroid disease during early, middle, late pregnancy, and postpartum period5
Immune cell infiltration and drug sensitivity in PIK3CA-mutated esophageal squamous cell carcinoma: A TCGA database analysis5
P522 Characterization of linkage disequilibrium between DRB1*01 and DRB54
O39 Characterization of HLA expression on memory-like (ML) NK cells4
JoGo-LILR caller: Unveiling and navigating the diversity of LILRB3-LILRA6 copy number structures with whole-genome sequencing4
Serological reactivity of HLA alleles is dependent on race/ethnicity4
P222 Using epitope analysis to aid in test interpretation and to guide donor matching for a highly sensitized patient4
P707 Performance and evaluation of a novel NGS assay and software for monitoring dd-cfDNA following kidney transplantation4
Concurrent use of two independent methods prevents erroneous HLA typing of deceased organ donors – An important strategy for patient safety and accurate virtual crossmatching for broader sharing4
Chimeric antigen receptor natural killer cell therapy: A systematic review of preclinical studies for hematologic and solid malignancies4
P514 High background challenges in single antigen bead assay4
P204 Use of cell-free DNA analysis to determine need for renal transplant biopsy after detection of circulating donor-specific anti-HLA antibodies in renal transplant recipients4
O12 Identification of DRB1 and DQB1 amino acid variability within serologic antigen groups4
Effect modification between HLA-F and CD56 markers reveals differences in survival for triple-negative breast cancer patients4
P212 Investigating HLA-DQ immunogenicity in lung transplantation4
Comparison of alloimmune risk stratification method for kidney transplants: Correlation with outcomes from a single center pediatric transplant program4
HLA-B evolutionary divergence is associated with outcomes after SARS-CoV-2 infection4
Decoding immune tolerance in infertility: Exploring immune pathways and non-coding RNAs as pioneering biomarkers and therapeutic targets4
P521 Assessment of HLA-associated type 1 diabetes risk in Haiti4
Not all eplet mismatches are created equal – A cohort study illustrating implications to long-term graft outcomes4
P115 Assessment of chimerism by next generation sequencing: A comparison to STR/qPCR methods4
Front Matter4
Comparison between two commercially available Luminex non-HLA antibody assays4
lncRNA-mediated immune system dysregulation in RIF; a comprehensive insight into immunological modifications and signaling pathways’ dysregulation4
P509 Natural knockouts: HLA genotypes with no expressed alleles4
The number and frequency of mucosal-associated invariant T (MAIT), γδ T, and innate lymphoid cells (ILCs) altered in patients with type I Gaucher disease4
MiR-155 regulates Th9 differentiation in children with methicillin-resistant Staphylococcus aureus pneumonia by targeting SIRT14
Performance assessment of the One Lambda Devyser Accept cfDNA assay in lung transplantation3
Autobiographical perspectives on HLA epitopes: Past, present and future3
Dynamics of HLA and angiotensin II type 1 receptor antibodies during pregnancy3
How natural selection shapes genetic differentiation in the MHC region: A case study with Native Americans3
Successful third transplant for recurrent leukemia after TLI-ATG conditioning and despite EBV-associated mixed donor chimerism3
P112 Integrating the Oxford Nanopore MinION bioinformatic pipeline into an HLA laboratory information management system for high-resolution typing workflow3
O23 NGS HLA typing reveals low-level maternal T cell engraftment through the detection of an unexpected DRB43
Coexistence of sickle cell disease and systemic lupus erythematosus is associated with quantitative and qualitative impairments in circulating regulatory B cells3
Suppressor T helper type 17 cell responses in intestinal transplant recipients with allograft rejection3
The use of business intelligence software to promote quality and service excellence of laboratory operations3
Differential adsorption of HLA and non-HLA antibodies following combined liver and kidney transplantation3
HLA-DRB3/4/5 mismatches were unintentionally avoided in allogenic hematopoietic stem cell transplants3
miR-150 promotes progressive T cell differentiation via inhibiting FOXP1 and RC3H13
Polymorphisms of B-lymphocyte-associated genes CD20 and FCRL5 are associated with susceptibility to autoimmune thyroid diseases3
Virtual crossmatch (VXM) by the numbers3
P519 Deciphering the loss of anti-angiotensin type 1 receptor reactivity in enzyme-linked immunosorbent assay post-adsorption3
Cytokine Dysregulation in pulmonary Tuberculosis: The role of TNF-α/IL-10 and TNF-α/TGF-β ratios as severity indicators3
Association of serum level of TGF-B1 and its genetic polymorphisms (C509T and T869C) with Ischemic heart disease in Iraqi population3
Exhausted NK cells and cytokine storms in COVID-19: Whether NK cell therapy could be a therapeutic choice3
Varying potency of self/cancer peptides in KIR3DL1 recognition of HLA-A*24:023
Multi-center evaluation of 19 loci hybrid capture NGS assay on illumina instruments3
A case-control association study of APOE promoter region variants with glaucoma in North Indian population3
Increased frequency of CD14+HLA-DR-/low cells in type 2 diabetes patients with poor glycemic control3
Improvements of Omixon NanoTYPE HLA typing using Oxford Nanopore Technologies: Addressing the DQ3 drop-out issue3
P207 Virtual crossmatch: Could all HLA-DQB1*03:01P antigens be analyzed in the same way?3
Astragalus-mediated stimulation on antigen-presenting cells could result in higher IL-21 production from CXCR5+ Tfh-like cells and better IL-21-mediated effector functions3
The impact of donor-specific antibody and non-HLA antibodies on acute cellular rejection in pediatric liver transplantation3
O28 Interrogating DSA IgG characteristics and effector functions in lung transplant recipients3
Undetected mixed chimerism in myeloid subset enrichments by an immunomagnetic bead-based method3
Allelic Polymorphisms of Killer Immunoglobulin-Like Receptor Genes in Malay and Orang Asli Populations of Peninsular Malaysia2
P230 Donor-specific HLA antibody characteristics at the time of biopsy with and without antibody-mediated rejection in kidney transplantation2
Association of IL10 gene SNVs rs1800896 (A>G), rs1800871 (C>T), rs1800872 (C>A) and haplotypes with COVID-19 severity and outcome in the Brazilian population2
O13 The accuracy of eplet mismatching using imputed intermediate resolution HLA typing2
A glance at the geographical distribution of histocompatibility laboratories2
Validating residues determining epitopes and its possible application in clinical histocompatibility testing2
O26 The performance of a research hybrid-capture NGS assay for high-resolution HLA typing2
P525 Cracking the code: Exploring the connection between COVID-19 vaccines and HLA antibodies in kidney transplant candidates2
UCLA International MICA Exchange – An update2
High-resolution MHC sequencing reveals local genetic architecture of multiple sclerosis in a trans-ethnic cohort2
O7 Combining allele-specific solvent-accessible surface-protruding amino acid mismatches and predicted indirect T cell epitopes improves HLA matching in predicting kidney graft survival2
Genome Canada precision medicine strategy for structured national implementation of epitope matching in renal transplantation2
Applications of next-generation sequencing in hematologic malignancies2
Association between oral nutrition and inflammation after intestinal transplantation2
TNFRSF13B in B cell responses to organ transplantation2
Next generation sequencing for HLA loci in full heritage Pima Indians of Arizona, Part II: HLA-A, -B, and -C with selected non-classical loci at 4-field resolution from whole genome sequences2
P202 Belimumab causes positive B cell flow cytometric crossmatches with untreated lymphocytes but not with pronase-treated lymphocytes2
P225 Daratumumab-induced interference with HLA crossmatching in cardiac amyloidosis patients awaiting heart transplantation2
Author Index2
Differential gene expression of immune response in COVID-19 and its relationship with progression of COVID-192
O11 A computational HLA allele-typing protocol to de-noise and leverage nanopore amplicon data2
P218 Association of HLA-DRB1*04 with acute severe hepatitis of unknown aetiology in children: Results from an Irish cohort2
Integrating US census demographic data with HLA frequencies to accelerate targeted cell therapy patient enrollment2
P109 The DRB4*03:01N allele confounds NGS typing software2
P224 Reporting a rare KIR genotype lacking framework genes2
The functional TNFAIP3 rs2230926T/G (Phe127Cys) variant confers risk to systemic lupus erythematosus in a Latin American population2
Expression of concern: “Humoral immune mechanisms involved in protective and pathological immunity during COVID-19” [Hum. Immunol. 82(10) (2021) 733–745]2
Genetic variants in the NF-κB signaling pathway (NFKB1, NFKBIA, NFKBIZ) and risk of critical outcome among COVID-19 patients2
Combining nano-curcumin with catechin improves COVID-19-infected patient's inflammatory conditions2
Vitamin D decreases expression of NLRP1 and NLRP3 inflammasomes in placental explants from women with preeclampsia cultured with hydrogen peroxide2
Anti-inflammatory action of geopropolis produced by stingless bees on human peripheral blood mononuclear cells2
O34 HLA-typing using a long-read HLA capture method combined with ONT or PacBio sequencing2
Nomenclature for factors of the HLA system, update January, February and March 20232
HLA homozygosity is associated with Non-Hodgkin lymphoma2
Nomenclature for factors of the HLA system, update July, August and September 20222
P617 Alloimmune endotypes and related outcomes in human liver transplantation2
HLA-DPB1 and DPA1∼DPB1 linkage mismatch affects the survival of recipients receiving HLA-14/14 matched unrelated donor HSCT2
High-throughput, high-resolution HLA typing using NGS-Pronto nanopore sequencing – a multicentre performance study2
P106 DP mischievous: Case reports of isolated de nove DP donor specific antibodies2
Donor genetic determinant of thymopoiesis, rs2204985, and stem cell transplantation outcome in a multipopulation cohort2
Is peripheral blood immunophenotyping useful to understand the etiology of Idiopathic Granulomatous?2
Role of inflammation and immune response in atherosclerosis: Mechanisms, modulations, and therapeutic targets2
P606 Basecalling accuray of HLA loci using rapid Nanopore sequencing2
0.30779600143433